Amendment Number Two AgreementAmendment Agreement • January 26th, 2024 • APRINOIA Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledJanuary 26th, 2024 Company IndustryThis Amendment Agreement (the “Number Two Agreement”) is entered into as indicated below, among National Institutes for Quantum and Radiological Science and Technology (“QST”), a research institute in Japan, having an address at 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan, APRINOIA Therapeutics Inc. (“APRINOIA TW”), a corporation of Taiwan, having an address at 17F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan and APRINOIA Therapeutics Inc. (“APRINOIA KY”), a corporation of Cayman Islands, having an address at The Grand Pavilion Commercial Centre, Oleander Way, 802 West Bay Road, P.O. Box 32052, Grand Cayman KY1-1208, Cayman Islands, in consideration of the mutual agreement to make alterations to the Exclusive License Agreement (the “Original Agreement”) executed on October 20th, 2016 by QST and APRINOIA TW and the Amendment Agreement (the “Number One Agreement”) executed on January 11th ,2018 by QST, APRINOIA TW and APRINOIA KY.
Amendment Number Two AgreementAmendment Agreement • November 13th, 2023 • APRINOIA Therapeutics Inc. • Pharmaceutical preparations
Contract Type FiledNovember 13th, 2023 Company IndustryThis Amendment Agreement (the “Number Two Agreement”) is entered into as indicated below, among National Institutes for Quantum and Radiological Science and Technology (“QST”), a research institute in Japan, having an address at 4-9-1 Anagawa, Inage-ku, Chiba-shi, Chiba 263-8555, Japan, APRINOIA Therapeutics Inc. (“APRINOIA TW”), a corporation of Taiwan, having an address at 17F., No.3, Park St., Nangang Dist., Taipei City 11503, Taiwan and APRINOIA Therapeutics Inc. (“APRINOIA KY”), a corporation of Cayman Islands, having an address at The Grand Pavilion Commercial Centre, Oleander Way, 802 West Bay Road, P.O. Box 32052, Grand Cayman KY1-1208, Cayman Islands, in consideration of the mutual agreement to make alterations to the Exclusive License Agreement (the “Original Agreement”) executed on October 20th, 2016 by QST and APRINOIA TW and the Amendment Agreement (the “Number One Agreement”) executed on January 11th ,2018 by QST, APRINOIA TW and APRINOIA KY.